Showing results (41-50 of 148) with videos related to
Sort By:
Pageof 15
Neuroscience Letters|September 3, 2004
Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 geneDavid Craig, Dominic J Hart, Robyn Carson, et al.Annals of Neurology|July 6, 2004
The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementiaDavid Craig, Dominic J Hart, Keira McCool, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtypingBernadette McGuinness, Suzanne L Barrett, John McIlvenna, et al.Journal of Alzheimer'S Disease : JAD|December 8, 2015
Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal StudyBernadette McGuinness, Marc Fuchs, Suzanne L Barrett, et al.Neuroscience Letters|June 9, 2004
Allelic variation at the A218C tryptophan hydroxylase polymorphism influences agitation and aggression in Alzheimer's diseaseDavid Craig, Dominic J Hart, Robin Carson, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's diseaseDavid Craig, Ajay Mirakhur, Dominic J Hart, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 1, 2015
Age-Related Macular Degeneration-Associated Genes in Alzheimer DiseaseMichael A Williams, Gareth J McKay, Robyn Carson, et al.Journal of Alzheimer'S Disease : JAD|January 16, 2015
Plasma Complement factor H in Alzheimer's DiseaseMichael A Williams, David Haughton, Michael Stevenson, et al.Journal of Genetic Counseling|February 7, 2024
Exploring genetic counselors' experiences with non-paternity in clinical settingsEmma Cunningham, Stephen Hays, Tasha Wainstein, et al.Stroke|October 5, 2002
Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern IrelandStephen P McIlroy, Kevin B Dynan, John T Lawson, et al.Pageof 15